Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 28 Jan 2026. The item focuses on Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII). Review the original article for the full source wording and details.
Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 28 Jan 2026.
The item focuses on Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).
Review the original article for the full source wording and details.